Vestibular Nutrition for Meniere's Disease and Other Health Conditions

Connecting the Dots: Ménière’s Disease and Vestibular Nutrition in the Context of Other Health Conditions

When people think of Ménière’s disease, they think of fluctuating hearing loss, aural fullness, tinnitus, and vertigo. These are common symptoms many people experience. There is no clear cause and no cure, but the way that Ménière’s disease develops and progresses is thought “to involve a multifactorial disequilibrium of inner-ear homeostasis, with endolymphatic hydrops as the final common pathway”. (1) In other words, development is based on many factors that cause a change in the natural balance of the inner ear, which leads to an excessive buildup of fluid in the inner ear. ^(1,2)

Treatment and Symptom Management

On its own, Ménière’s disease symptoms can sometimes be managed with a combination of dietary, lifestyle, and medical interventions. These can include restricting salt, alcohol, and caffeine intake, and using diuretics or Betahistine (although not FDA-approved in the U.S.). ⁽²⁾ Treatments can expand to include surgical or procedural non-destructive and destructive techniques. (1) It is very difficult to assess the effectiveness of these treatments due to the variability and fluctuating nature of the disease, as well as the almost 70% rate of placebo response. ^(1,3) However, estimates suggest that 70- 85% of patients are well controlled with medication, lifestyle adjustments, and a low-sodium diet. ^(4,5)

The Link Between Diet and Ménière’s Symptoms

The research on dietary interventions for Ménière’s is mixed. Some studies have shown no apparent link between diet interventions and Ménière’s disease. Other studies show that a low-sodium diet with adequate water intake improves symptoms, specifically hearing, vertigo, and tinnitus. ⁽⁶⁾ Referral to a Registered Dietitian can help improve outcomes in medical management of Ménière’s disease. ⁽⁷⁾

Despite this mixed research, the Clinical Practice Guidelines (CPG) still recommend with a high level of confidence (in Statement #8) that “Clinicians should educate patients with Ménière’s disease on dietary and lifestyle modifications that may reduce or prevent symptoms.” ⁽⁸⁾ The guidelines are not specific about what that means exactly but point to the American Heart Association’s recommended range of 1,500–2,300 mg of sodium per day for most adults and state that further research is needed in this area. ⁽⁸⁾

Lifestyle Interventions

Dietary approaches that support whole-body fluid balance may also help reduce fluctuations in endolymphatic pressure. The DASH (Dietary Approaches to Stop Hypertension) diet has been shown to improve audiovestibular symptoms through stabilizing the vascular system. Its mechanism of action combines low sodium with high potassium, magnesium, and calcium, along with the potential protective effects of antioxidant vitamins (A, C, and E). For tinnitus specifically, it helps by reducing pro-inflammatory chemicals in the body and supporting vascular health. Conversely, high-fat, high-carbohydrate, and simple-sugar diets may worsen audiovestibular dysfunction through pro-inflammatory chemicals. ⁽⁹⁾

Quite surprisingly, one of the lifestyle interventions that has recently emerged for tinnitus control is weight management, including diet and exercise regimens. This is likely because it addresses whole-body inflammation and focuses on overall diet quality rather than single dietary components. ⁽⁹⁾

Managing Ménière’s with Coexisting Health Conditions

Many people with Ménière’s disease and vestibular disorders have a high rate of other health conditions. The most prevalent include hypertension, sleep disorders, and diabetes mellitus. What happens when dietary recommendations for Ménière’s disease need to be combined with those for another health condition? How can people manage their diets when recommendations for different conditions conflict?

Coexisting conditions, along with anxiety and depression, can significantly impact quality of life and worsen disease severity. Therefore, screening and treating all coexisting health issues, both mental and physical, should be part of Ménière’s disease management. ^(3,10) In this article, we will discuss some of these conditions and how dietary recommendations for each can be combined.

Vestibular Migraine

According to Cleveland Clinic, vestibular migraine is a neurological disorder that may cause common migraine symptoms along with vertigo and balance issues. ⁽¹¹⁾ It is one of the two most common episodic vestibular syndromes; the other being Ménière’s disease. ⁽¹²⁾ In Ménière’s patients, 45% consistently experienced at least one migraine-like symptom (e.g., headache, photophobia, aura) during vertigo attacks.

In one study, it was found that Ménière’s disease (MD) patients had a 2.22x higher risk of migraine, and those with migraine had a 1.95x higher risk of Ménière’s disease. ^(2,12) The significant symptom overlap between these two conditions suggests a potential pathophysiological association between the two. (1) However, migraine and Ménière’s disease have different immune responses at the cellular level, indicating different underlying causes and triggers. ⁽¹³⁾ Pyykko et al. conclude, “we consider it safe that migraine is treated and analyzed separately from MD, although these are undoubtedly associated.” ⁽¹⁰⁾

A 2023 Cochrane review analyzed lifestyle modifications for vestibular migraine (VM) and concluded that there is little evidence supporting these interventions for VM. In the absence of sufficient data, interventions from migraine headache studies have been used for treatment and management of VM. ^(1,2) Evidence-based lifestyle interventions for standard migraines, and therefore VM, include proper sleep hygiene and a consistent sleep schedule, stress management, regular physical activity, maintaining a healthy body habitus, preventing hunger and dehydration, and identifying and eliminating triggers (e.g., heat, loud sounds, strong odors, bright lights, diet).

For some people, dietary triggers may include, but are not limited to, caffeine, tyramine, monosodium glutamate, alcohol, chocolate, aged cheese, red wine, processed meats, and histamine. Some patients also benefit from supplementing coenzyme Q10, vitamin B2, and magnesium, particularly those who have a magnesium deficiency, which has been noted in people with migraine. Riboflavin and magnesium have also been found to contribute to migraine prevention.

Lifestyle and dietary changes have been shown to play an important role in improving vestibular symptoms. ^(2,14,15) In some cases, patients had faster improvement with these modifications than with medication intervention, but on average, about 70% of patients had improvement with diet and lifestyle modifications and medications used together. ^(14,15)

Although dietary factors have been recognized for many years as potential migraine triggers, more recent research has shifted its focus from individual foods to broader dietary patterns. Evidence is mixed for individual food triggers, but higher overall diet quality is associated with better migraine outcomes, with results sometimes as quickly as 4 weeks. ⁽¹⁶⁾ However, the optimal treatment for VM is likely medication as well as diet and lifestyle modifications. ⁽¹⁴⁾

Many of these diet and lifestyle interventions can be combined with the Ménière’s diet, making it more manageable for patients with both. For example, avoiding caffeine and alcohol may help patients who experience these as triggers for multiple conditions. However, managing multiple dietary triggers can be more challenging for patients with vestibular disease. It’s important to ensure they still get the nutrients they need and maintain a balanced diet while trying to reduce attacks and support overall health. This may require an individualized nutrition plan (Medical Nutrition Therapy – MNT) and guidance from a Registered Dietitian (RD) with knowledge of vestibular conditions.

Ménière’s Disease and High Blood Pressure (Hypertension)

Hypertension or high blood pressure is defined by the American Heart Association as blood pressure (BP) consistently greater than 130/80 mm Hg. ⁽¹⁷⁾ High blood pressure can affect physical, mental, and social quality of life. ⁽³⁾ Cardiovascular risk factors such as hypertension, smoking, obesity, diabetes, and altered lipid profile are well-known causes of small blood vessel integrity disruption, cellular-level stress, and damage to the blood-brain and blood-labyrinth barriers. This can make the inner ear an end-organ target of cardiovascular disease. ⁽⁴⁾

One study found that those with Ménière’s disease seemed to have an overall higher cardiovascular risk, especially due to hypertension. ^(3,4) Another large-scale epidemiological study supported this finding, further adding evidence that vascular dysregulation plays a role in disrupting inner ear balance and therefore the development of endolymphatic hydrops. ⁽³⁾ These cardiovascular risk factors can therefore influence the course of Ménière’s disease, and could even be responsible for certain subtypes with worse prognosis. ⁽⁴⁾

One study hypothesized that vasopressin, a naturally occurring peptide in the body, facilitates the balance of fluids in the inner ear, specifically endolymphatic fluid. Vasopressin is also a known major peptide hormone in the cardiovascular system. Higher amounts of plasma vasopressin, in the setting of salt-sensitive hypertension, may significantly influence or contribute to the symptoms of Ménière’s disease. ⁽⁴⁾

Salt restriction (sodium) is regarded as a core dietary intervention for both MD and hypertensive patients. ^(3,4) This is primarily because Ménière’s disease treatment is based on improving inner ear blood supply and reducing inner ear fluid volume. Lower salt helps both Ménière’s disease and hypertension by reducing arterial blood pressure. ⁽⁴⁾

Overall, diet patterns like the Mediterranean and DASH [Dietary Approaches to Stop Hypertension] diets can be extremely beneficial for both Ménière’s disease and hypertension. The Mediterranean diet is high in antioxidants, omega-3 polyunsaturated fatty acids, and dietary fiber, all of which have well-known systemic anti-inflammatory and vascular effects. The DASH diet is lower in sodium, higher in potassium, and decreases or eliminates alcohol intake. ^(9,17) This diet is specifically recommended for hypertension management, but it is also great for Ménière’s disease management, overall cardiovascular health, and optimal renal function. ⁽¹⁸⁾

Ménière’s Disease and Diabetes

The American Diabetes Association defines Type 2 diabetes mellitus as occurring when the body does not use insulin properly, known as insulin resistance. In the early stages of the disease, cells in the pancreas make extra insulin, but over time the pancreas is not able to make enough insulin to keep blood glucose at normal levels. ⁽¹⁹⁾

The role of glucose-insulin metabolism has been gaining attention in the world of neuro-otology. High glycemic index and excess simple-sugar diets cause rapid, significant changes in blood glucose and insulin levels. These spikes can disrupt normal inner ear balance, including cochlear and balance system function, through vascular stress, chronic low-grade inflammation, and shifts in inner-ear fluid and pressure. ^(3,9,20)

Improving overall diet quality while limiting added salt, sugars, and simple carbohydrates is a good combined diet plan for both type 2 diabetes and Ménière’s disease. One example of how to fill your plate when managing diabetes is ½ non-starchy veggies, ¼ lean protein, ¼ quality carbs, and an unsweetened drink. (21) This can also work well for Ménière’s management, assuming certain limits on added salt.

Ménière’s Disease and Thyroid Disease

One study observed that people with Ménière’s disease and thyroid problems had vertigo more often, which negatively affected quality of life, increased chronic fatigue, and other cognitive issues. In Finland, where this study was conducted, 14.7% of those with Ménière’s Disease also had thyroid disease. This is much higher than in the general population, where only 4-5% of people have thyroid disorders. ⁽¹⁰⁾

In fact, a meta-analysis found an association between goiter, hypothyroidism, and hyperthyroidism and Ménière’s disease. It also found that treating the thyroid problems improved both thyroid and Ménière’s symptoms. The authors hypothesized that this may indicate a role for hormonal imbalance in disrupting inner ear fluid regulation. ⁽³⁾

There is no set diet for thyroid disease, but a balanced diet with essential nutrients like iodine and selenium is important. While iodine is mainly in iodized salt, it is also found in seafood and dairy products, allowing a good balance between sodium and iodine for those with Ménière’s and thyroid disease.

Ménière’s Disease and Kidney Disease

The incidence of coexisting chronic kidney disease (CKD) and Ménière’s disease is not well established. The current recommendation for CKD stages 3-5 for sodium is less than 2,300 mg, and for potassium is to “adjust dietary intake to maintain serum potassium within the normal range.” ⁽²²⁾ This sodium intake aligns with general dietary recommendations for people with Ménière’s disease. Potassium intake, however, depends largely on blood levels and other health factors to maintain normal levels, as recommended for the Ménière’s diet.

Other beneficial nutrients, such as phosphorus and calcium, should follow CKD guidelines, since they are important for overall health but not directly linked to the Ménière’s disease diet.

Ménière’s Disease and Postural Orthostatic Tachycardia Syndrome (POTS):

Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic disabling condition that causes a variety of symptoms when changing positions from lying down to standing up or worsening of symptoms when upright, then improvement of symptoms when lying back down. Symptoms include dizziness, fatigue, and a fast heart rate (an increase of at least 30 beats per minute) with no hypotension (low blood pressure). Prevalence appears to be 0.2–1.0% of the North American population. There is no cure, but treatments can help manage symptoms. ⁽²³⁾

One of the main treatments for POTS is a high-sodium diet, usually about 6-10 g of sodium per day, and increased water intake, although various studies have shown this may not be enough to completely normalize symptoms. This may be due to disturbed pathways involved in sodium retention regulation. However, a high-sodium diet remains one of the main treatment interventions, especially for reducing the risk of syncope and associated falls. ^(23,24)

The prevalence of coexisting POTS and Ménière’s disease has not been well established.  However, these 2 diet interventions are in direct conflict, since the Ménière’s diet recommends a low-sodium diet and the POTS diet recommends a high-sodium diet. Reconciliation of these two diet interventions would need to be done under medical supervision to establish the ideal balance of sodium for people who have both Ménière’s and POTS.

Moving Forward with Ménière’s Disease and other Comorbidities

Many of the metabolic–vascular comorbidities seem to act as significant symptom modifiers in MD. This supports screening and focused treatment of these comorbidities in clinical protocols. Hypertension, diabetes mellitus, thyroid disorders, and vestibular migraine can directly aggravate the inner ear and vestibular symptoms of MD, making patients feel worse and exacerbating symptoms. ⁽³⁾

For many of the comorbidities discussed in this article, diets similar to the Ménière’s diet can be effective comorbidity management tools and lead to improved overall health. With the exception of POTS, overall diet quality and pattern can be more important than individual foods when managing many of the comorbidities discussed in this article. These nuances underscore the importance of providing individualized Medical Nutrition Therapy only under the supervision of a Registered Dietitian experienced in Meniere’s disease, Vestibular Migraine, and comorbid management.

About the Author

Dr. Ramona Ramdath, RD, PhD, is a Registered Dietitian and founder of Meniere’s Dietitian. She holds a PhD in Biomedical Sciences from the University of Toledo, a Master’s in Biochemistry from the University of Sussex, and completed her dietetics training at the University of Arizona.

Dr. Ramdath’s focus on nutrition for vestibular migraine and Meniere’s disease is deeply personal. Her husband, a physician living with Meniere’s disease, experienced life-changing symptom relief through her unique Medical Nutrition Therapy. His success and the success of so many of her vestibular patients from across the country continue to fuel her desire to help people find symptom relief.

References: 

1. Strupp M, Dlugaiczyk J, Ertl-Wagner BB, Rujescu D, Westhofen M, Dieterich M. Vestibular Disorders. Dtsch Arztebl Int. 2020;117(17):300-310. doi:10.3238/arztebl.2020.0300
2. Hac NEF, Gold DR. Advances in diagnosis and treatment of vestibular migraine and the vestibular disorders it mimics. Neurotherapeutics. 2024;21(4):e00381. doi:10.1016/j.neurot.2024.e00381
3. Zhang Z, Jiao L, Zhang G, et al. Comorbidities and impact on quality of life in patients with Ménière’s disease: a single-center cross-sectional study. Front Neurol. 2026;17:1855669. Published 2026 Jun 24. doi:10.3389/fneur.2026.1855669
4. Rego ÂR, Dias D, Pinto A, E Castro SS, Feliciano T, E Sousa CA. The cardiovascular aspects of a Ménière’s disease population – A pilot study. J Otol. 2019;14(2):51-56. doi:10.1016/j.joto.2019.01.004
5. Oğuz E, Cebeci A, Geçici CR. The relationship between nutrition and Ménière’s disease. Auris Nasus Larynx. 2021;48(5):803-808. doi:10.1016/j.anl.2021.03.006
6. Yang, X., Lin, C., Wu, Q., Li, L., & Mei, X. (2024). Low-sodium diet with adequate water intake improved the clinical efficacy in Ménière’s disease. Acta Oto-Laryngologica, 144(1), 14–18. https://doi.org/10.1080/00016489.2024.2315302
7. Luxford E, Berliner KI, Lee J, Luxford WM. Dietary modification as adjunct treatment in Ménière’s disease: patient willingness and ability to comply. Otol Neurotol. 2013;34(8):1438-1443. doi:10.1097/MAO.0b013e3182942261
8. Basura, G.J., Adams, M.E., Monfared, A., Schwartz, S.R., Antonelli, P.J., Burkard, R., Bush, M.L., Bykowski, J., Colandrea, M., Derebery, J., Kelly, E.A., Kerber, K.A., Koopman, C.F., Kuch, A.A., Marcolini, E., McKinnon, B.J., Ruckenstein, M.J., Valenzuela, C.V., Vosooney, A., Walsh, S.A., Nnacheta, L.C., Dhepyasuwan, N. and Buchanan, E.M. (2020), Clinical Practice Guideline: Ménière’s Disease. Otolaryngology–Head and Neck Surgery, 162: S1-S55. https://doi.org/10.1177/0194599820909438
9. Klimas M, Jucha D, Krupa-Nurcek S. Nutritional Strategies and Dietary Patterns in Ménière’s Disease and Tinnitus: A Scoping Review of the Available Evidence. Nutrients. 2026;18(13):2102. Published 2026 Jun 27. doi:10.3390/nu18132102
10. Pyykkö I, Vinay, Zou J, Vetkas A, Manchaiah V. Diverse phenotype of Ménière’s disease associated with family history, thyroid disorder, migraine and associated disorders. J Otol. 2024;19(4):185-192. doi:10.1016/j.joto.2024.07.005
11. Cleveland Clinic. Vestibular migraine. Cleveland Clinic. Updated August 10, 2026. Accessed October 22, 2026. https://my.clevelandclinic.org/health/diseases/25217-vestibular-migraine
12. Huppert D, Grill E, Becker-Bense S, Zwergal A, Strobl R. Diagnostic challenges in vestibular migraine-clinical differentiation from Ménière’s disease and discrepancies with current classification criteria. J Neurol. 2025 Aug 5;272(9):558. doi: 10.1007/s00415-025-13291-x. PMID: 40762827; PMCID: PMC12325411.
13. Cruz-Granados P, Frejo L, Perez-Carpena P, Amor-Dorado JC, Dominguez-Duran E, Fernandez-Nava MJ, et al. Multiomic-based immune response profiling in migraine, vestibular migraine and Ménière’s disease. Immunology. 2024; 173(4): 768–779. https://doi.org/10.1111/imm.13863
14. Frank M, Tawk K, Lee EJ, et al. Efficacy of Nortriptyline and Migraine Lifestyle Modifications in Vestibular Migraine Management. Clin Otolaryngol. 2025;50(1):62-67. doi:10.1111/coa.14231
15. Shen Y, Qi X, Wan T. The Treatment of Vestibular Migraine: A Narrative Review. Ann Indian Acad Neurol. 2020;23(5):602-607. doi:10.4103/aian.AIAN_591_19
16. Asakura S, Kamogashira T, Funayama H, et al. Diet-Related Quality of Life Reflects Psychological and Autonomic Burden in Patients with Dizziness and Balance Disorders: A Cross-Sectional Study. Nutrients. 2026;18(13):2044. Published 2026 Jun 23. doi:10.3390/nu18132044
17. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152(11):e114-e218. doi:10.1161/CIR.0000000000001356
18. Miyashita T, Inamoto R, Fukuda S, et al. Hormonal changes following a low-salt diet in patients with Ménière’s disease. Auris Nasus Larynx. 2017;44(1):52-57. doi:10.1016/j.anl.2016.03.001
19. American Diabetes Association. (2026). Understanding Type 2 Diabetes. Retrieved from https://diabetes.org/about-diabetes/type-2
20. Gioacchini FM, Albera R, Re M, Scarpa A, Cassandro C, Cassandro E. Hyperglycemia and diabetes mellitus are related to vestibular organs dysfunction: truth or suggestion? A literature review. Acta Diabetol. 2018 Dec;55(12):1201-1207. doi: 10.1007/s00592-018-1183-2. Epub 2018 Jun 23. PMID: 29936650.
21. American Diabetes Association Nutrition & Wellness Team. (2026, May 14). What is the diabetes plate? American Diabetes Association.
22. Ikizler T, Burrowes J, Byham-Gray L. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases, 76, S1-S107
23. Garland EM, Gamboa A, Nwazue VC, et al. Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome. J Am Coll Cardiol. 2021;77(17):2174-2184. doi:10.1016/j.jacc.2021.03.005
24. Williams EL, Raj SR, Schondorf R, Shen WK, Wieling W, Claydon VE. Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome. Auton Neurosci. 2022;237:102906. doi:10.1016/j.autneu.2021.102906